Growing evidence indicates that ribosome processivity during the translation of mRNA to proteins is exquisitely sensitive to changes in tRNA expression and processing. Perturbation of these processes contribute to aberrant cellular homeostasis that manifests as cancer or neurodegeneration. In a N-ethyl-N-nitrosourea (ENU) mutagenesis forward genetic screen in C57BL/6J (B6J) mice to identify novel genes regulating neuronal homeostasis, my lab identified a new ribosome rescue protein GTPBP2. Additionally, we identified a mutation in n-Tr20, a tRNAArgUCU that is specifically expressed in neurons, in B6J mice that epistatically interacts to cause neurodegeneration in Gtpbp2-/- mice. This mutation reduces the processing of n-Tr20 which in turn reduces the total pool of tRNAArgUCU in the brain causing ribosome stalling that is normally rescued by wild type GTPBP2. Interestingly, expression of n-Tr20 is restricted to the brain. These results established ribosome stalling as a novel mechanism for neurodegeneration and defined n-Tr20 as the first reported neuron-specific tRNA in vertebrates. Subsequent mapping crosses of B6J-Gtpbp-/- mice have identified a BALB/cByJ-derived locus that enhances neurodegeneration. Although we have narrowed the critical region containing this modifier gene, no causal gene or mechanism have been identified.
In Aim 1 of this proposal, I have proposed a research strategy to identify the causative gene for this locus and elucidate the mechanisms by which this modifier gene augments neurodegeneration.
In Aim 2, I will investigate the prevalence of cell-type tRNA expression in the brain by generating the first in vivo tRNA expression brain atlas. I will accomplish this aim by first generating a knock-in mouse line to conditionally epitope-tag RNA Polymerase III (Pol III), the RNA polymerase responsible for transcribing all tRNA, and then performing ChIP-sequencing to determine the occupancy of Pol III machinery on tRNA genes isolated from specific cell-types. With the completion of this proposal we expect to reveal the vast complexity of cell-type specific tRNA profiles in the mammalian brain, and new mechanisms of dysregulation that contribute to aberrant ribosome processivity and neuronal homeostasis in specific cell-types.

Public Health Relevance

The discovery of the neural specific tRNA n-Tr20 highlights the fundamental importance of cell-type specific tRNAs in neuronal homeostasis, mutations in which epistatically interact with the ribosome recycling factor GTPBP2 to cause ribosome stalling during translation elongation and neurodegeneration. Here I propose to identify a new modifier gene of GTPBP2 that exacerbates neurodegeneration and to provide the first in vivo cell-type specific tRNA expression brain atlas. The proposed study will shed light on the vast complexity of the tRNA repertoire in the mammalian brain and is essential for our mechanistic understanding of the dynamic regulation of protein synthesis by ribosomes and tRNA.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
1F32NS111857-01
Application #
9759723
Study Section
Neurological Sciences Training Initial Review Group (NST)
Program Officer
Gubitz, Amelie
Project Start
2019-06-01
Project End
2020-09-30
Budget Start
2019-06-01
Budget End
2020-05-31
Support Year
1
Fiscal Year
2019
Total Cost
Indirect Cost
Name
University of California, San Diego
Department
Other Basic Sciences
Type
Schools of Medicine
DUNS #
804355790
City
La Jolla
State
CA
Country
United States
Zip Code
92093